Analysts think SER stock price could increase by 113%
Apr 07, 2025, 11:25 AM
9.82%
What does SER do
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
2 analysts think SER stock price will increase by 112.90%. The current median analyst target is $11.22 compared to a current stock price of $5.27. The lowest analysts target is $11.11 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
